Keyphrases
Vascular Endothelial Growth Factor Receptor (VEGFR)
100%
Mesoporous Silica Nanoparticles
100%
Tumor-targeted Delivery
100%
VEGF121
100%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
50%
U87MG
33%
Sunitinib
33%
Polyethylene Glycol
16%
Tumor
16%
Positron Emission Tomography
16%
Drug Administration
16%
Vascular Endothelial Growth Factor
16%
Ligand-receptor Binding
16%
Tumor Angiogenesis
16%
Signaling Cascades
16%
Tumor Metastasis
16%
Malignant Glioma
16%
Receptor Targets
16%
Therapeutic Efficacy
16%
Ex Vivo Studies
16%
Murine Model
16%
Nanoplatform
16%
Human Glioblastoma
16%
Potential Side Effects
16%
Growth Factor Receptor Signaling
16%
In Vitro-in Vivo
16%
Theranostic Nanomedicine
16%
Radioisotopes
16%
Medicine and Dentistry
Neoplasm
100%
Vasculotropin Receptor
100%
Mesoporous Silica Nanoparticle
100%
Drug Delivery System
100%
Glioblastoma
33%
Sunitinib
33%
Combination Therapy
16%
Metastatic Carcinoma
16%
In Vitro
16%
Side Effect
16%
Ex Vivo
16%
Drug Administration
16%
Macrogol
16%
Radioisotope
16%
Positron Emission Tomography
16%
Vasculotropin
16%
Tumor Angiogenesis
16%
Copper 64
16%
Cancer
16%
Nanomedicine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Delivery System
100%
Vasculotropin Receptor
100%
Targeted Drug Delivery
100%
Mesoporous Silica Nanoparticle
100%
Neoplasm
100%
Glioblastoma
33%
Sunitinib
33%
Radioisotope
16%
Drug Administration
16%
Side Effect
16%
Vasculotropin
16%
Macrogol
16%
Copper 64
16%
Combination Therapy
16%
Nanomedicine
16%
Material Science
Tumor
100%
Mesoporous Silica
100%
Silica Nanoparticle
100%
Polyethylene Glycol
25%
Tomography
25%